Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
Crossref DOI link: https://doi.org/10.1007/s12325-016-0443-1
Published Online: 2016-12-02
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harrington, Rachel
Lee, Edward
Yang, Hongbo
Wei, Jin
Messali, Andrew
Azie, Nkechi
Wu, Eric Q.
Spalding, James
Funding for this research was provided by:
Astellas Pharma Global Development